Produktname:Ethyl 2-diazo-2-(diethoxyphosphoryl)acetate

IUPAC Name:ethyl 2-diazo-2-(diethoxyphosphoryl)acetate

CAS:17507-56-1
Molekulare Formel:C8H15N2O5P
Reinheit:95%+
Katalognummer:CM1075898
Molekulargewicht:250.19

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM1075898-1g in stock Ǝũǜ
CM1075898-5g in stock NJưȺ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:17507-56-1
Molekulare Formel:C8H15N2O5P
Schmelzpunkt:-
SMILES-Code:[N-]=[N+]=C(C(=O)OCC)P(=O)(OCC)OCC
Dichte:
Katalognummer:CM1075898
Molekulargewicht:250.19
Siedepunkt:
Mdl-Nr.:
Lagerung:

Column Infos

ORIC-533
ORIC-533 is a potential best-in-class, oral inhibitor of CD73 developed by ORIC Pharmaceuticals which is currently in a Ph. Ib trial for the treatment of relapsed/refractory multiple myeloma (MM). It inhibits the CD73-mediated conversion of AMP to adenosine which generates an immunosuppressive tumor microenvironment and has the potential to be a next-generation immunotherapy. The in-depth use of co-crystal structures led the team to discover a novel set of phosphonate bioisosteres which were able to achieve bioavailability for a highly polar scaffold. The structure and discovery story of ORIC-533 were recently presented at the ACS Spring 2024 Meeting in New Orleans.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.